Novartis India Limited(IN:NOVARTIND)
₹1,368.25-26.00 (-1.86%)
IN:NOVARTIND
Novartis India Limited financials statements
₹1,368.25
At close:-26.00 (-1.86%)
Want to see IN:NOVARTIND full AI Analyst Report?
Novartis India Limited (NOVARTIND) Financial Statements
1 Followers
Novartis India Limited Financial Overview
Novartis India Limited's market cap is currently ₹47.86B. The company's EPS TTM is ₹-1.60; its P/E ratio is -862.50; and it has a dividend yield of 1.54%. Novartis India Limited has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ₹ 3.54B | ₹ 3.98B | ₹ 3.35B | ₹ 3.79B | ₹ 3.88B |
| Gross Profit | ₹ 1.33B | ₹ 1.53B | ₹ 1.32B | ₹ 1.77B | ₹ 2.06B |
| Operating Income | ₹ 921.50M | ₹ 1.32B | ₹ 1.10B | ₹ 600.80M | ₹ 237.70M |
| EBITDA | ₹ 941.00M | ₹ 1.33B | ₹ 652.60M | ₹ 1.23B | ₹ 106.60M |
| Net Income | ₹ 931.80M | ₹ 1.01B | ₹ 851.90M | ₹ 1.03B | ₹ -37.20M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ₹ 6.68B | ₹ 6.37B | ₹ 5.85B | ₹ 5.70B | ₹ 5.16B |
| Total Assets | ₹ 9.78B | ₹ 9.48B | ₹ 9.25B | ₹ 9.83B | ₹ 9.58B |
| Total Debt | ₹ 32.10M | ₹ 50.60M | ₹ 69.70M | ₹ 215.10M | ₹ 240.10M |
| Net Debt | ₹ -6.64B | ₹ -6.43B | ₹ -380.10M | ₹ 20.90M | ₹ -1.34B |
| Total Liabilities | ₹ 1.60B | ₹ 1.63B | ₹ 1.80B | ₹ 2.07B | ₹ 2.66B |
| Stockholders' Equity | ₹ 8.18B | ₹ 7.85B | ₹ 7.45B | ₹ 7.76B | ₹ 6.92B |
| Cash Flow | |||||
| Free Cash Flow | ₹ 843.60M | ₹ 745.70M | ₹ 1.48B | ₹ 444.90M | ₹ 381.70M |
| Operating Cash Flow | ₹ 847.00M | ₹ 745.70M | ₹ 1.13B | ₹ 448.00M | ₹ 386.70M |
| Investing Cash Flow | ₹ -203.40M | ₹ -33.10M | ₹ 331.30M | ₹ -1.53B | ₹ 870.40M |
| Financing Cash Flow | ₹ -639.30M | ₹ -641.50M | ₹ -1.21B | ₹ -304.80M | ₹ -356.30M |
Currency in INR
